Nepromol – IV
Established in 2019, Insight Medicare is a dynamic and fast-growing Indian pharmaceutical company headquartered in Mumbai.
Nepromol – IV
Nepromol-IV is a ready-to-use intravenous Paracetamol infusion for rapid relief from fever and moderate pain. It ensures fast, effective, and controlled delivery of analgesic and antipyretic action in hospital settings.
Product Description
Indication
Intravenous (IV) paracetamol is licensed for the short-term treatment of moderate pain, especially following surgery, and for the short-term treatment of fever, when administration by the IV route is clinically justified by an urgent need to treat pain or hyperthermia.
Dose Reduction Factors
Low body weight: less than 50kg
Hepatic impairment
Chronic alcoholism
Dehydration
Receiving enzyme inducers chronically e.g. rifampicin, phenytoin, carbamazepine, St John’s wort
Risk factors for glutathione depletion e.g. HIV, cystic fibrosis, chronic malnutrition
DOSING GUIDE
| Weight | Single dose | Maximum daily dose |
|---|---|---|
| 33–50kg regardless of risk factors | 15mg/kg every 4–6 hours* (max four times daily) | 60mg/kg up to 3g in 24 hours |
| >50kg with risk factors | 1g every 8 hours | 60mg/kg up to 3g in 24 hours |
| >50kg without risk factors | 1g every 4–6 hours* (max four times daily) | 60mg/kg up to 4g in 24 hours |
Related Products
